Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.27 USD | -36.51% | -33.64% | +0.65% |
May. 09 | Craig-Hallum Adjusts Cardlytics Price Target to $12 From $18, Maintains Buy Rating | MT |
May. 09 | Needham Adjusts Price Target on Cardlytics to $12 From $17, Keeps Buy Rating | MT |
Evolution of the average Target Price on Cardlytics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Cardlytics, Inc.
Craig-Hallum | |
Needham & Co. | |
Lake Street | |
Wells Fargo Securities | |
JPMorgan Chase | |
BofA Securities | |
J.P. Morgan Chase | |
William Blair & Co. |
EPS Revisions
- Stock Market
- Equities
- CDLX Stock
- Consensus Cardlytics, Inc.